High-grade invasive urothelial and intraepithelial carcinomas with high SOX9 expression were poorly differentiated tumors, suggesting that tumor cells have acquired diversity and are capable of various differentiations as a result of enhanced transcription factor function. This evidence concerns the gene SOX9 and in situ carcinoma.